Japan Seeks ¥20 Billion In Spending Cuts With Generic Utilization
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Japan Prime Minister Taro Aso's government Dec. 16 unveiled a draft proposal to finance natural social security expenditures growth in fiscal 2009 partly with ¥20 billion in spending cuts for prescription drugs by encouraging the use of generic drugs
You may also be interested in...
Japanese Pharma Expects New Deal Model For Next 20 Years - New York Pharma Forum
NEW YORK - When the New York Pharma Forum, a group consisting primarily of Japanese pharmaceutical executives, gathered for its 20th General Assembly, members reflected on their companies' early days in the U.S. and their prospects for the future, when the scope of partnerships between Western pharma and Asia Pacific pharma will begin to change
Japanese Pharma Expects New Deal Model For Next 20 Years - New York Pharma Forum
NEW YORK - When the New York Pharma Forum, a group consisting primarily of Japanese pharmaceutical executives, gathered for its 20th General Assembly, members reflected on their companies' early days in the U.S. and their prospects for the future, when the scope of partnerships between Western pharma and Asia Pacific pharma will begin to change
Japan’s Slow Generic Use Caused By Physician Attitudes, Survey Says
TOKYO - Generic drugs' penetration into the Japanese pharmaceutical market has been languishing below 20 percent, and as many as 83 percent of consumers said their physicians have not recommended they switch from brand drugs, according to a survey released by research firm Ishare, Oct. 20